Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

Sheela Rao,David Cunningham,Robert E. Hawkins,Mark Hill,David B. Smith,Francis Daniel,P. Ross,Jeremy E Oates,A. Norman

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

2005

Sheela Rao
David Cunningham
Robert E. Hawkins
Mark Hill
David B. Smith
Francis Daniel
P. Ross
Jeremy E Oates
A. Norman

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

Keywords:

Pathology
Etoposide
Fluorouracil
Immunology
Cisplatin
Medicine
Cancer
Epirubicin
Chemotherapy
Biliary tract
Biliary tract neoplasm
Survival analysis
Neutropenia
Bolus (digestion)
symptomatic relief

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

130

Citations